PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

NEW GLOBAL CONTRACT

4 Jun 2007 07:00

Byotrol PLC04 June 2007 BYOTROL NEW GLOBAL CONTRACT ANNOUNCEMENT The Directors of Byotrol plc (the "Company") are pleased to be able to report anew global contract that has been secured by the Company. The Company has worked in partnership to develop a range of productsincorporating Byotrol(R) technology for Fellowes Inc, a leading global providerof office accessories and business machines. As a global provider, Fellowes has access to a wide range of disinfectanttechnologies and chose Byotrol for its residual efficacy, ultra low toxicityprofile and broadband action against a wide range of micro-organisms. Fellowes is launching the Virashield(TM) range of products containing Byotrolacross Europe with a global launch planned in the near future. The range, whichincludes wipes and hand protection foam, is designed to help combat the spreadof infections in the workplace. Virashield(TM) offers both residual efficacy ofup to seven days coupled with broad spectrum capability against a wide range oforganisms including viruses such as influenza and avian flu and bacteriaincluding E.coli. Research has shown that a typical office desk harbours up to400 times more bacteria than a typical toilet seat and the residual efficacyoffered by the Virashield range containing Byotrol will help office workerscombat this real and growing risk of infection. The Virashield(TM) range has been extensively tested by both Byotrol andFellowes and the tests have proven the product's efficacy for up to seven daysfollowing application. The range can both remove microbes from surfaces in anoffice environment and keep the surface microbially clean for this period oftime. Byotrol plc Chief Executive David McRobbie said, "We are delighted to havesecured our first contract that will make Byotrol available on a global basisand that a company the size of Fellowes chose Byotrol as its worldwide strategicpartner for this key product launch. There is growing awareness thatmicro-organisms are not just an issue in hospitals and specialist environmentsand that effective cleaning regimes have a role in a wider range of settings." Headquartered in Illinois, USA with subsidiaries in Canada, Benelux, France,Germany, Italy, Poland, Spain, UK, China, Singapore, Japan, Korea and Australia,they have an extensive distribution & export network reaching over 100countries. Fellowes employs more than 2,700 people throughout the world andexpects global sales in excess of $700 million this year. Enquiries: Byotrol plc 0161 277 9518Stephen Falder Deputy Chairman Richard Bell 07825 204 110Finance Director Charles Stanley Securities 020 7149 6457Philip Davies McCann Erickson PR 01625 822540Jim Rothnie Rawlings Financial 01756 770376John Rawlings This information is provided by RNS The company news service from the London Stock Exchange

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.